China Science and Technology Innovation operates as an investment firm.
China Science and Technology Innovation operates as an investment firm.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jan 12, 2023
LePure Biotech
|
Series C | — | Biopharma | — |
Apr 13, 2022
Guangdong Gaojing Solar Energy Technology
|
Series A | ¥1.60B | Energy | — |
Mar 18, 2022
Xinling Pharmaceutical
|
Seed | ¥100M | — | |
Dec 20, 2021
Vastai Technologies
|
Series B | ¥1.60B | Artificial Intelligence | — |
Mar 17, 2021
Akang health
|
Series B | ¥200M | Health Care | — |